Mesoblast Ltd (AU:MSB) — Stock Price

AU$2.36 AUD
▲ 5.83% today

Mesoblast Ltd (AU:MSB) is currently trading at AU$2.36 AUD, up 5.83% today. Over the past 52 weeks, shares have ranged between AU$1.89 and AU$3.07. This page tracks Mesoblast Ltd's live share price on the AU exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see MSB market cap overview.

Mesoblast Ltd (MSB) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Mesoblast Ltd's daily closing share price and trading volume on the AU exchange over the past year, giving a clear view of recent price momentum and liquidity.

Mesoblast Ltd Income Statement — Revenue, Profit & Earnings by Year

Mesoblast Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue AU$17.20 Million AU$5.90 Million AU$7.50 Million AU$10.21 Million AU$7.46 Million
Cost of Revenue AU$5.13 Million AU$41.07 Million AU$54.92 Million AU$63.57 Million AU$85.73 Million
Gross Profit AU$12.07 Million AU$-35.17 Million AU$-47.42 Million AU$-53.36 Million AU$-78.28 Million
Research & Development AU$34.81 Million AU$25.35 Million AU$27.19 Million AU$32.81 Million AU$53.01 Million
SG&A AU$23.21 Million AU$23.63 Million AU$25.37 Million AU$27.21 Million AU$30.87 Million
Total Operating Expenses AU$74.51 Million AU$48.98 Million AU$76.79 Million AU$90.78 Million AU$115.06 Million
Operating Income AU$-62.44 Million AU$-84.15 Million AU$-69.29 Million AU$-80.57 Million AU$-109.10 Million
EBITDA AU$-73.66 Million AU$-56.08 Million AU$-58.55 Million AU$-76.57 Million AU$-84.65 Million
EBIT AU$-80.06 Million AU$-57.97 Million AU$-62.66 Million AU$-80.95 Million AU$-88.92 Million
Interest Expense AU$21.75 Million AU$20.66 Million AU$19.44 Million AU$17.29 Million AU$10.71 Million
Income Before Tax AU$-101.81 Million AU$-88.15 Million AU$-82.10 Million AU$-91.59 Million AU$-99.63 Million
Income Tax Expense AU$330.00K AU$-191.00K AU$-212.00K AU$-239.00K AU$-819.00K
Net Income AU$-102.14 Million AU$-87.96 Million AU$-81.89 Million AU$-91.35 Million AU$-98.81 Million

Mesoblast Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Mesoblast Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets AU$784.68 Million AU$669.15 Million AU$669.41 Million AU$662.14 Million AU$744.72 Million
Total Current Assets AU$204.35 Million AU$86.46 Million AU$81.66 Million AU$69.84 Million AU$148.23 Million
Cash & Equivalents AU$-2.00K AU$13.00K AU$-49.00K
Short-term Investments
Net Receivables AU$14.87 Million AU$20.95 Million AU$7.00 Million AU$4.40 Million AU$4.59 Million
Inventory AU$22.25 Million AU$2.55 Million AU$-4.32 Million AU$-252.00K
Property, Plant & Equipment AU$5.82 Million AU$3.84 Million AU$6.49 Million AU$9.96 Million AU$12.14 Million
Goodwill AU$134.45 Million AU$134.45 Million AU$134.45 Million AU$134.45 Million AU$134.45 Million
Total Liabilities AU$187.24 Million AU$188.80 Million AU$167.58 Million AU$165.10 Million AU$163.32 Million
Total Current Liabilities AU$102.63 Million AU$73.24 Million AU$41.98 Million AU$51.37 Million AU$94.27 Million
Long-term Debt AU$67.74 Million AU$100.48 Million AU$102.81 Million AU$91.62 Million AU$41.05 Million
Net Debt AU$-33.00 Million AU$56.36 Million AU$45.58 Million AU$46.87 Million AU$-31.39 Million
Total Stockholder Equity AU$597.44 Million AU$480.36 Million AU$501.84 Million AU$497.04 Million AU$581.40 Million
Retained Earnings AU$-1.01 Billion AU$-908.76 Million AU$-820.80 Million AU$-738.92 Million AU$-647.57 Million

Mesoblast Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Mesoblast Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow AU$-49.95 Million AU$-48.46 Million AU$-63.27 Million AU$-65.78 Million AU$-106.68 Million
Capital Expenditures AU$730.00K AU$331.00K AU$314.00K AU$232.00K AU$1.65 Million
Free Cash Flow AU$-50.68 Million AU$-48.79 Million AU$-63.58 Million AU$-66.01 Million AU$-108.33 Million
Investing Cash Flow AU$120.00K AU$-97.00K AU$-194.00K AU$-232.00K AU$-1.65 Million
Financing Cash Flow AU$147.34 Million AU$40.25 Million AU$74.50 Million AU$-9.87 Million AU$114.47 Million
Dividends Paid AU$0.00 AU$0.00 AU$0.00 AU$0.00 AU$0.00
Stock-Based Compensation AU$22.09 Million AU$5.87 Million AU$3.65 Million AU$5.54 Million AU$12.51 Million
Depreciation AU$6.40 Million AU$4.67 Million AU$4.11 Million AU$4.38 Million AU$4.26 Million
Change in Cash AU$98.59 Million AU$-8.36 Million AU$10.87 Million AU$-76.43 Million AU$7.55 Million

Mesoblast Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Mesoblast Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 27, 2026
May 29, 2026 0.00 -0.01 +100.00%
Feb 26, 2026 0.00
Nov 26, 2025 -0.01 -0.01 +30.00%
Aug 28, 2025 -0.04 -0.04 +0.00%
May 30, 2025 0.00 -0.01 +100.00%
Feb 26, 2025 -0.04 -0.02 -100.00%
Nov 20, 2024 -0.01 -0.01 -40.00%